November 12, 2014
ISSN: 1578-147X (Electronic)
Original Publication: Pancreatitis del surco en el diagnostico diferencial del adenocarcinoma de pancreas.
Accession Number: 24314608
Notes: Palomeque Jimenez, Antonio
Perez Cabrera, Beatriz
Navarro Freire, Francisco
Jimenez Rios, Jose Antonio
Cir Esp. 2014 Feb;92(2):127-9. doi: 10.1016/j.ciresp.2013.10.003. Epub 2013 Dec 4.
Author Address: Servicio de Cirugia General y del Aparato Digestivo, Unidad de Cirugia Hepatobiliopancreatica, Hospital Universitario San Cecilio, Granada, Espana. Electronic address: email@example.com.
Servicio de Cirugia General y del Aparato Digestivo, Unidad de Cirugia Hepatobiliopancreatica, Hospital Universitario San Cecilio, Granada, Espana.
Reference Type: Journal Article
Record Number: 4741Author: Pandey, K., Singh, D., Lal, C. S., Das, V. N. and Das, P.
Title: Fatal acute pancreatitis in a patient with visceral leishmaniasis during miltefosine treatment
Journal: J Postgrad Med
Short Title: Fatal acute pancreatitis in a patient with visceral leishmaniasis during miltefosine treatment
Alternate Journal: Journal of postgraduate medicine
ISSN: 0022-3859 (Print)
Accession Number: 24346389
Abstract: Pancreatitis is a known side effect of the once commonly used drug, sodium stibogluconate, for treatment of visceral leishmaniasis (VL). In India, miltefosine has recently been introduced as the first-line drug. Its side effects include loose motions, vomiting, and teratogenicity. We report here a case of a 41-year-old parasitologically confirmed male case of VL, who developed acute pancreatitis during treatment with miltefosine. On the 13 th day of treatment, he presented with abdominal pain and vomiting. The biochemical, hematological, and radiological features were suggestive of acute pancreatitis. The patient was put on conservative treatment for pancreatitis at the specialized center but succumbed to renal failure and septicaemia.